MNTA - Momenta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.2B
Enterprise Value 3895.67M
Trailing P/E N/A
Forward P/E 1-7.54
PEG Ratio (5 yr expected) 10.05
Price/Sales (ttm)16.01
Price/Book (mrq)2.85
Enterprise Value/Revenue 311.97
Enterprise Value/EBITDA 6-6.07

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -231.49%
Operating Margin (ttm)-217.21%

Management Effectiveness

Return on Assets (ttm)-20.83%
Return on Equity (ttm)-45.78%

Income Statement

Revenue (ttm)74.85M
Revenue Per Share (ttm)0.90
Quarterly Revenue Growth (yoy)-15.20%
Gross Profit (ttm)25.59M
EBITDA -147.44M
Net Income Avi to Common (ttm)-173.27M
Diluted EPS (ttm)-2.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)335.27M
Total Cash Per Share (mrq)3.53
Total Debt (mrq)91.5M
Total Debt/Equity (mrq)21.65
Current Ratio (mrq)6.71
Book Value Per Share (mrq)4.43

Cash Flow Statement

Operating Cash Flow (ttm)-155.03M
Levered Free Cash Flow (ttm)-60.61M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.38
52-Week Change 3-46.76%
S&P500 52-Week Change 34.08%
52 Week High 332.20
52 Week Low 39.55
50-Day Moving Average 312.96
200-Day Moving Average 312.84

Share Statistics

Avg Vol (3 month) 3446.55k
Avg Vol (10 day) 3377.6k
Shares Outstanding 595.11M
Float 93.55M
% Held by Insiders 12.07%
% Held by Institutions 198.05%
Shares Short (May 31, 2019) 43.57M
Short Ratio (May 31, 2019) 47.65
Short % of Float (May 31, 2019) 46.04%
Short % of Shares Outstanding (May 31, 2019) 43.62%
Shares Short (prior month Apr 30, 2019) 43.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A